Anyone wishing to nominate a substance to the Revised In Commerce List (“R-ICL”) must do so before November 3, 2019. On November 3, 2019, the nomination process ends and no further nominations will be accepted.
The R-ICL is a list of substances that were in Canadian commerce between January 1987 and September 2001 contained in products regulated under the Food and Drugs Act (“FDA”).
Any person in Canada involved with the manufacture, import, distribution, or use of an eligible substance may submit a nomination for a substance to the R-ICL until November 3, 2019. Foreign suppliers may also make nominations, provided that the nomination is made through a person resident in Canada and authorized to act on behalf of the foreign supplier.
Click here to read the full article.